Clinical trial
Safety, Efficacy and Pharmacokinetics of Subcutaneous ACZ885 in Patients With…
NCT00426218 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00426218 |
|---|---|
| Title | Safety, Efficacy and Pharmacokinetics of Subcutaneous ACZ885 in Patients With Systemic Juvenile Idiopathic Arthritis (SJIA) |
| Official title | Safety, Efficacy and Pharmacokinetics of Subcutaneous ACZ885 in Patients With Systemic Juvenile Idiopathic Arthritis (SJIA) |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Arthritis, Juvenile Rheumatoid |
| Intervention type | Drug |
| Interventions | ACZ885 |
| Enrollment | 26 |
| Start date | Dec 1, 2006 |
| Primary completion | Mar 1, 2010 |
| First posted | Jan 24, 2007 |
| Last update posted | Aug 9, 2011 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: